Patient Pathway

by Boehringer Ingelheim

This program offers a range of services to help alleviate financial concerns around access. It includes resources and guidance to help patients understand treatment with GILOTRIF, which is used to treat people with non-small cell lung cancer (NSCLC). The Co-pay Assistance Program ensures eligible patients pay no more than $0 per month for GILOTRIF (conditions apply).

Patient/Care Partner Ratings

View Online Rate it

Your feedback is important! Please add your rating and review of this resource.

Pay it forward. We are constantly updating our site, and understanding how helpful a resource was, allows us to make continuous improvements.

Was it easy to use/content easy to understand?

Did it provide you with information you were looking for, answer a question or simplify a question/issue you had?

Did you learn something new and/or did it help you make a decision?

Would you recommend to someone else?

Additional Comments:

The Gilotrif Co-pay Assistance Program

Your feedback is important! Please add your rating and review of this resource.

Pay it forward. We are constantly updating our site, and understanding how helpful a resource was, allows us to make continuous improvements.